ADMA BIOLOGICS, INC. Quarterly Operating Income (Loss) in USD from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Adma Biologics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2011 to Q3 2024.
  • Adma Biologics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $39.6M, a 356% increase year-over-year.
  • Adma Biologics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $115M, a 8471% increase year-over-year.
  • Adma Biologics, Inc. annual Operating Income (Loss) for 2023 was $21.6M.
  • Adma Biologics, Inc. annual Operating Income (Loss) for 2022 was -$39.4M, a 32.6% increase from 2021.
  • Adma Biologics, Inc. annual Operating Income (Loss) for 2021 was -$58.4M, a 10.1% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $115M $39.6M +$31M +356% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $83.9M $39.2M +$39.7M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $44.3M $21.8M +$22.6M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $21.6M $14.2M +$20.3M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $1.34M $8.69M +$18M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$16.7M -$473K +$8.7M +94.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$25.4M -$813K +$14M +94.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$39.4M -$6.06M +$7.13M +54.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$46.5M -$9.32M +$5.12M +35.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$51.6M -$9.17M +$6.41M +41.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$58M -$14.8M +$349K +2.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$58.4M -$13.2M +$4.03M +23.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$62.4M -$14.4M -$636K -4.61% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$61.8M -$15.6M +$1.54M +9.01% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$63.3M -$15.2M +$1.61M +9.57% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$64.9M -$17.2M -$9.39M -120% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 -$55.5M -$13.8M -$4.75M -52.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$50.8M -$17.1M -$5.79M -51% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$45M -$16.8M -$3.56M -27% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$41.4M -$7.83M +$8.72M +52.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 -$50.1M -$9.05M +$4.74M +34.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$54.9M -$11.3M +$2.08M +15.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$57M -$13.2M +$3.32M +20.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$60.3M -$16.5M -$6M -56.9% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-13
Q3 2018 -$54.3M -$13.8M +$636K +4.41% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$54.9M -$13.4M -$5.02M -59.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$49.9M -$16.5M -$10.6M -178% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$39.3M -$10.5M -$6.6M -167% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-13
Q3 2017 -$32.7M -$14.4M -$10.7M -286% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$22M -$8.4M -$2.91M -53% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$19.1M -$5.94M -$1.78M -42.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$17.3M -$3.94M +$187K +4.52% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-29
Q3 2016 -$17.5M -$3.74M +$927K +19.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 -$18.4M -$5.49M -$1.97M -56.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$16.5M -$4.16M -$956K -29.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$15.5M -$4.13M -$422K -11.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-24
Q3 2015 -$15.1M -$4.66M -$1.63M -53.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$13.5M -$3.52M +$70.7K +1.97% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 -$13.5M -$3.2M +$2.48M +43.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$16M -$3.71M +$809K +17.9% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-23
Q3 2014 -$16.8M -$3.04M -$507K -20% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 -$16.3M -$3.59M +$1.26M +25.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 -$17.6M -$5.68M -$2.53M -80.4% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 -$15M -$4.52M -$2.28M -102% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-09
Q3 2013 -$12.8M -$2.53M +$718K +22.1% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$13.5M -$4.84M -$3.64M -301% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 -$9.85M -$3.15M -$1.94M -160% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$7.91M -$2.24M -$2.12M -1742% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-28
Q3 2012 -$5.79M -$3.25M -$2.48M -323% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$3.31M -$1.21M +$941K +43.8% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-12
Q1 2012 -$4.25M -$1.21M +$372K +23.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 -$4.62M -$122K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-06
Q3 2011 -$768K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$2.15M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$1.59M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.